Lysosomes, Peroxisomes & the Chemistry of Degradation

1. Acidification and the V-ATPase

Lysosomal pH is maintained by the vacuolar H⁺-ATPase (V-ATPase), a rotary proton pump cousin to F₁F₀ but running in reverse: it consumes ATP to pump protons into the lumen. The steady-state pH is set by a balance between V-ATPase flux and proton leak through the limiting membrane and through coupled counter-ion channels (principally ClC-7/OSTM1, which exchange 2 Cl⁻ per H⁺to dissipate electrical but not chemical pmf):

\[ \mathrm{pH}_{\mathrm{lumen}}^{\mathrm{ss}} = \mathrm{pH}_{\mathrm{cyto}} - \dfrac{1}{\ln 10}\ln\!\left[\dfrac{J_{\mathrm{pump}}}{J_{\mathrm{leak}}}\right] \]

The factor-of-1000 [H⁺] gradient thus corresponds to a ~18 k_BT free-energy gradient per proton — the same order as ΔG_ATP, which is why one ATP is consumed per 2–3 protons pumped (V-ATPase has a c-ring of 10, α₃β₃catalytic head, and runs with the F-type mechanism in reverse).

2. The Endosome–Lysosome Maturation Ladder

Lysosomes are the terminus of an acidification gradient:

• Early endosome — pH 6.0–6.5, Rab5-positive, sorting station for recycling vs degradation.
• Late endosome / multivesicular body— pH 5.0–5.5, Rab7-positive, invaginates its limiting membrane to internalise cargo (ESCRT machinery).
• Lysosome — pH 4.5–5.0, LAMP1/LAMP2 on limiting membrane, heavily N-glycosylated to protect against its own hydrolases.

Each rung of this ladder is a stable steady state set by different pump:leak ratios; each has its characteristic pH-tuned activities (e.g. the late-endosomal hydrolases are maximally active at pH 5–5.5, some lysosomal enzymes require pH < 5 to uncover their zymogen activation loop).

3. Why Acid? — pKa Engineering of Hydrolases

Lysosomal hydrolases are evolved to be catalytically active only below pH 5.5. A cathepsin inadvertently released into the cytosol (pH 7.4) is near-inactive on the timescale of a cell’s emergency response; this is not coincidence but design. The mechanism is simple: active-site histidines, aspartates, or glutamates with shifted pKa's are protonated and catalytically competent only at low pH. A cathepsin-D active-site aspartate with pKa ~ 4.5 follows:

\[ f_{\mathrm{active}}(\mathrm{pH}) = \dfrac{1}{1 + 10^{\mathrm{pH} - \mathrm{pK_a}}} \]

So activity drops by a factor of ~10³ between lysosomal pH 4.5 and cytosolic pH 7.4 — just the safety margin the cell needs. This “biochemical fail-safe by pH” is a recurring motif: the same principle protects the cell from the Ca²⁺-dependent caspases (low cytosolic Ca²⁺ keeps them latent) and the Ca²⁺-dependent phospholipase A₂.

Simulation: pKa & V-ATPase Set-Point

4. Cargo Delivery: Endocytosis, Phagocytosis, Autophagy

Three distinct pathways deliver cargo to the lysosome:

• Endocytosis — clathrin-coated, caveolar, or CLIC/GEEC routes pick up receptors and their ligands from the plasma membrane; vesicles mature through the early/late endosome ladder.
• Phagocytosis — actin-driven engulfment of particles > 0.5 μm (apoptotic bodies, bacteria). Used constitutively by macrophages and dendritic cells; transiently by most cells.
• Autophagy — self-degradation. A double-membrane phagophore engulfs cytoplasmic contents (including whole organelles: mitophagy, ER-phagy, ribophagy), matures into an autophagosome, and fuses with the lysosome. Ohsumi’s 2016 Nobel. Substrate selection uses autophagy-receptor proteins (p62/SQSTM1, NBR1, NDP52, OPTN) that bind ubiquitin on the cargo side and LC3 on the phagophore side.

5. Lysosomal Storage Disorders

Defective catabolism at the lysosome is the physical basis of more than 50 recognised inborn errors of metabolism — Gaucher(glucocerebrosidase, GBA), Fabry(α-galactosidase A), Pompe(α-glucosidase, glycogen accumulation), Niemann–Pick(sphingomyelinase), Tay–Sachs(hexosaminidase A). Each traces to a single missing or inactive hydrolase, whose substrate accumulates in the lysosome until the organelle loses function.

These diseases are, in effect, thermodynamic traffic jams: a compartment designed for continuous throughput becomes a reservoir, and its cargo begins to cross-react with the machinery designed to process it. Enzyme replacement therapy (ERT: recombinant enzyme with mannose-6-phosphate tag directing lysosomal uptake) is now standard of care for several LSDs. GBA mutations are also the strongest single genetic risk factor for sporadic Parkinson’s disease — a direct link between lysosomal function and neurodegeneration.

Simulation: LSD Substrate Accumulation

6. Peroxisomes: The Oxidation Compartment

Peroxisomes are smaller (100–500 nm) single-membrane organelles containing enzymes that generate H₂O₂ as a reaction byproduct (very-long-chain fatty-acid β-oxidation, D-amino-acid oxidation, purine catabolism) and the catalase that destroys it. The logic is local containment of a reactive species whose cytosolic release would be mutagenic.

Peroxisomal biogenesis is unusual. Peroxisomes arise both by fission of existing peroxisomes (using a shared fission machinery with mitochondria: DRP1/DNM1L, MFF, FIS1) and by de novo budding from the ER: specialised pre-peroxisomal vesicles bud from ER exit sites, fuse with each other, and mature into mature peroxisomes. This dual origin was resolved in the last decade (Joshi 2016, Agrawal 2017).

Zellweger syndrome (loss of PEX genes encoding peroxins) abolishes peroxisome biogenesis and is fatal in infancy. X-linked adrenoleukodystrophy (ALD; ABCD1 mutations) disrupts VLCFA import and produces accumulation of VLCFAs in neurones — another example of a storage disorder, in an organelle most textbooks still dismiss as a minor curiosity.

7. Lysosomal Membrane Permeabilisation & Regulated Death

LMP releases lysosomal contents into the cytosol — cathepsins activate Bid (pro-apoptotic) or, at higher magnitudes, drive secondary necrosis. Low-level LMP is sensed by the galectin-3/galectin-8 system which recruits autophagy machinery to repair or replace damaged lysosomes (lysophagy). This surveillance is lost in some neurodegenerative conditions: mutations in GBA destabilise the limiting membrane, and the resulting chronic low-level LMP is one hypothesis for Gaucher’s strong link to Parkinson’s disease.